# Cochrane

# Trusted evidence.

# Informed decisions.

# Library

# Better health.

# Ananthakrishnan 2015

Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nature Reviews Gastroenterology and Hepatology 2015;12(4):205-17.

# Anderson 2012

Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 2012;36(6):503-16.

# Armuzzi 2012

Armuzzi A, van Assche G, Reinisch W, Pineton de Chambrun G, Griffiths A, Sladek M, et al. Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease. Journal of Crohn's and Colitis 2012;6(4):492-502.

# Cammarota 2015

Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Alimentary Pharmacology and Therapeutics 2015;41(9):835-43.

# Cammarota 2017

Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017;66(4):569-80.

# Carding 2017

Carding SR, Davis N, Hoyles L. Review article: the human intestinal virome in health and disease. Alimentary Pharmacology and Therapeutics 2017;46(9):800-15.

# Assa 2016

Assa A, Butcher J, Li J, Elkadri A, Sherman PM, Muise AM, et al. Mucosa-associated ileal microbiota in new-onset pediatric Crohn's disease. Inflammatory Bowel Diseases 2016;22(7):1533-9.

# Austin 2014

Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of Clostridium difficile infections. American Journal of Medicine 2014;127(6):479-83.

# Auzoux 2017

Auzoux J, Boschetti G, Lahlou W, Aubourg A, Girault A, Lecomte T, et al. Assessment of mucosal healing in inflammatory bowel disease. Journal of Clinical Gastroenterology and Hepatology 2017;1:1-8.

# Bahnam 2023

Bahnam P, Hanzel J, Ma C, Zou L, Narula N, Singh S, et al. Most placebo-controlled trials in inflammatory bowel disease were underpowered because of overestimated drug efficacy rates: results from a systematic review of induction studies. Journal of Crohn's and Colitis 2023;17(3):404-17.

# Bejaoui 2015

Bejaoui M, Sokol H, Marteau P. Targeting the microbiome in inflammatory bowel disease: critical evaluation of current concepts and moving to new horizons. Digestive Diseases 2015;33(Suppl 1):105-12.

# Blanton 2016

Blanton LV, Charbonneau MR, Salih T, Barratt MJ, Venkatesh S, Ilkaveya O, et al. Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science 2016;351(6275):10.1126/science.aad3311.

# Caldeira 2020

Caldeira LF, Borba HH, Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis. PLOS One 2020;15(9):e0238910.

# Davidovics 2019

Davidovics ZH, Michail S, Nicholson MR, Kociolek LK, Pai N, Hansen R, et al. Fecal microbiota transplantation for recurrent Clostridium difficile infection and other conditions in children: a Joint Position Paper From the North American Society for.

# Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.